Literature DB >> 11759889

Successful surgical treatment of a ruptured abdominal aortic aneurysm without homologous blood transfusion in a Jehovah's Witness: report of a case.

O Namura1, H Kanazawa, K Yoshiya, S Nakazawa, Y Yamazaki.   

Abstract

We report herein the case of a 47-year-old woman of the Jehovah's Witness faith in whom Y-grafting for a ruptured abdominal aortic aneurysm was successfully performed without a homologous blood transfusion. We used a Cell Saver (Haemonetics, Braintree, MA. USA) red cell salvaging device and an aortic occlusion balloon catheter, and performed gentle and minimal dissection during the operation. Postoperatively. the patient was kept heavily sedated and required hypothermic therapy for only 14h. We treated her severe anemia using conventional drugs, including iron and folic acid, and her hemoglobin increased smoothly. Although her hemoglobin level decreased to 2.8g/dl during the operation, her postoperative course was uneventful.

Entities:  

Mesh:

Year:  2001        PMID: 11759889     DOI: 10.1007/s005950170034

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Successful bowel surgery at hemoglobin 2 g/dL without blood transfusion.

Authors:  Ramakrishnapillai Padmakumar; Madhukara Pai; Shams Farish; Jayadevan Rajeev; Thampi Sanjeev; Thekke Veetil Sreevalsan; Binu Sheetal; Yesudas Santhakumari Sooraj; Shamna Safar Rowther
Journal:  World J Gastrointest Surg       Date:  2013-08-27

Review 2.  Resuscitative endovascular balloon occlusion of the aorta in combat casualties: The past, present, and future.

Authors:  Sarah C Stokes; Christina M Theodorou; Scott A Zakaluzny; Joseph J DuBose; Rachel M Russo
Journal:  J Trauma Acute Care Surg       Date:  2021-08-01       Impact factor: 3.697

Review 3.  A systematic review and meta-analysis of the use of resuscitative endovascular balloon occlusion of the aorta in the management of major exsanguination.

Authors:  B L S Borger van der Burg; Thijs T C F van Dongen; J J Morrison; P P A Hedeman Joosten; J J DuBose; T M Hörer; R Hoencamp
Journal:  Eur J Trauma Emerg Surg       Date:  2018-05-21       Impact factor: 3.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.